Brief: Nyrada Receives Written FDA Feedback For Xolatryp Cardioprotection Program
12/10/2026 22:18
BRIEF-Nyrada Receives Written FDA Feedback For Xolatryp Cardioprotection Program Oct 13 (Reuters) - Nyrada Inc NYR.AX:
RECEIVES WRITTEN FDA FEEDBACK ON PRE-IND FOR XOLATRYP CARDIOPROTECTION PROGRAM
Further company coverage: NYR.AX